KRISTINA CASSMEYER: Open Payments
NPI 1740757194 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 102 payments from 39 companies in 2025. Trend: 2023 $1,504 · 2024 $2,407 · 2025 $1,670
Food & beverage: $1,670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $364 |
| PFIZER INC. | 15 | $140 |
| Alexion Pharmaceuticals, Inc. | 3 | $66 |
| TG Therapeutics, Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| UCB, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| Lilly USA, LLC | 2 | $46 |
| Biogen, Inc. | 2 | $45 |
Products named: QULIPTA, BOTOX, NURTEC ODT, ULTOMIRIS, BRIUMVI, Rystiggo, HYQVIA, AUSTEDO XR.
Industry payments across KY — which companies pay providers there.
